Erol Veznedaroglu

Erol Veznedaroglu, MD, is the Robert A. Groff Chair in Neurosurgery and Interim Chair of Neurology at Drexel University College of Medicine. He founded the Capital Institute for Neurosciences and leads the Global Neurosciences Institute (GNI), a consortium advancing comprehensive neurologic care across vascular, tumor, spine, and functional domains. His clinical expertise spans stroke, aneurysms, arteriovenous malformations, and neurocritical care.

Education:

• MD - State University of New York at Buffalo School of Medicine (1996)
• BA - New York University (1989)

Research Focus: Dr. Veznedaroglu pioneers endovascular therapies for cerebrovascular disorders. His work integrates stroke prevention, novel thrombectomy devices, and intra-arterial drug delivery for glioblastoma. Research emphasizes clinical translation, with trials like DAWN (thrombectomy in wake-up strokes) and FRED (intracranial aneurysm devices).

Publication Trends: Recent articles reflect leadership in neurointerventional innovation, particularly thrombectomy techniques (Trevo/Solitaire devices), aneurysm management, and stroke systems optimization. Studies emphasize real-world efficacy, device safety, and protocol standardization.

Awards & Honors:

• NJ Biz Power 50 Health Care (2014)
• Top Doctors, South Jersey Magazine (2010-2013)
• Academics in Medicine Award (2013)
• Guide to America's Top Surgeons (2007-2012)
• William A Buchheit Teaching Awards (2004-2008)
• Science Educator Award, Society for Neuroscience (2005)

Grants & Leadership: Principal investigator for NIH-funded trials (e.g., POSITIVE, TREVO Registry) and industry studies (e.g., FRED, WEAVE). Directs GNI's multidisciplinary teams across 12+ subspecialties, including Alzheimer’s, Parkinson’s, and pediatric neurology.

Infrastructure: Established Capital Health's neuro-emergency department reducing door-to-needle times for stroke thrombolysis. Developed simulation-based training curricula for endovascular techniques adopted by AANS/CNS.